stella
beta
Real-World Study of Post-Resistance Treatment Strategies in Advanced Breast Cancer Following CDK4/6i, PIK3CA Inhibitors, or T-DXd — Stella
Home
/
Metastatic Breast Cancer
/
View on ClinicalTrials.gov
Recruiting
Back to Metastatic Breast Cancer trials
Trial locations
(1 site)
China
Hunan Cancer Hospital, Changsha, Hunan